Determination of HER2 amplification status on tumour DNA by digital PCR

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Garcia Murillas, Isaac ^a   Lambros, Maryou ^a   Turner, Nicholas C ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CHROMOSOME 17; CONTROLLED STUDY; DNA EXTRACTION; EFTUD2 GENE; GENE; GENE AMPLIFICATION; GENE DOSAGE; HER2 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEASUREMENT ACCURACY; MICRODISSECTION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 17; GENE AMPLIFICATION; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS; PEPTIDE ELONGATION FACTORS; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; SENSITIVITY AND SPECIFICITY;

EID: 84891313947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083409     Document Type: Article

References (18)

1. Hurvitz SA, Hu Y, O'Brien N, Finn RS (2013) Current approaches and future directions in the treatment of HER2-positive breast cancer. Cancer Treat Rev 39: 219-229.
2. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, et al. (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25: 118-145. (Pubitemid 350003059)
3. Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J et al. (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
4. Lehmann-Che J, Amira-Bouhidel F, Turpin E, Antoine M, Soliman H, et al. (2011) Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches. Br J Cancer 104: 1739-1746.
5. Moelans CB, de Weger RA, Ezendam C, van Diest PJ (2009) HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection. BMC Cancer 9: 4.
6. Whale AS, Huggett JF, Cowen S, Speirs V, Shaw J, et al. (2012) Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res 40: e82.
7. Heredia NJ, Belgrader P, Wang S, Koehler R, Regan J, et al. (2013) Droplet Digital PCR quantitation of HER2 expression in FFPE breast cancer samples. Methods 59: S20-23.
8. Muller BM, Kronenwett R, Hennig G, Euting H, Weber K, et al. (2011) Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue-a new option for predictive biomarker assessment in breast cancer. Diagn Mol Pathol 20: 1-10.
9. Baehner FL, Achacoso N, Maddala T, Shak S, Quesenberry Jr CP, et al. (2010) Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol 28: 4300-4306.
10. Dabbs DJ, Klein ME, Mohsin SK, Tubbs RR, Shuai Y, et al. (2011) High falsenegative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study. J Clin Oncol 29: 4279-4285.
11. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, et al. (1999) Comparative genomic hybridization of ductal carcinoma in situ of the breastevidence of multiple genetic pathways. J Pathol 187: 396-402. (Pubitemid 29118269)
12. Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, et al. (2007) BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26: 2126- 2132. (Pubitemid 46514749)
13. Buerger H, Schmidt H, Beckmann A, Zanker KS, Boecker W, et al. (2001) Genetic characterisation of invasive breast cancer: a comparison of CGH and PCR based multiplex microsatellite analysis. J Clin Pathol 54: 836-840. (Pubitemid 33063488)
14. Natrajan R, Mackay A, Wilkerson PM, Lambros MB, Wetterskog D, et al. (2012) Functional characterization of the 19q12 amplicon in grade III breast cancers. Breast Cancer Res 14: R53.
15. Gevensleben H, Garcia-Murillas I, Graeser MK, Schiavon G, Osin P, et al. (2013) Non-invasive detection of HER2 amplification with plasma DNA Digital PCR. Clin Cancer Res. 19 (12): 3276-84.
16. Dube S, Qin J, Ramakrishnan R (2008) Mathematical Analysis of Copy Number Variation in a DNA Sample Using Digital PCR on a Nanofluidic Device. PLoS ONE 3 (8): e287617.
17. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature 486: 346-352.
18. Garraway LA (2013) Genomics-Driven Oncology: Framework for an Emerging Paradigm. J Clin Oncol. 31 (15): 1806-14.